Table 1.
Baseline characteristics of patients.
| Patients (n = 210) | |
|---|---|
| Onset to admission time, days, mean ± SD | 2.469 ± 1.37 |
| Infarct volume, cm3, mean ± SD | 6.238 ± 24.90 |
| tPA treatment, n (%) | 27 (12.86%) |
| Admission | |
| NIHSS, mean ± SD | 3.938 ± 3.520 |
| mRS, mean ± SD | 2.086 ± 1.179 |
| GCS, mean ± SD | 14.61 ± 1.233 |
| systolic blood pressure, mmHg mean ± SD | 140.8 ± 19.63 |
| diastolic blood pressure, mmHg mean ± SD | 81.83 ± 10.69 |
| Blood LDL, mmol/l, mean ± SD | 2.936 ± 0.9711 |
| Discharge | |
| NIHSS, mean ± SD | 2.776 ± 2.647 |
| mRS, mean ± SD | 1.890 ± 1.242 |
| GCS, mean ± SD | 14.84 ± 0.6206 |
| systolic blood pressure, mmHg mean ± SD | 128 ± 15.02 |
| diastolic blood pressure, mmHg mean ± SD | 81.03 ± 8.949 |
| Blood LDL, mmol/l, mean ± SD | 2.671 ± 0.9622 |
| 3 months | |
| NIHSS, mean ± SD | 1.038 ± 0.3506 |
| mRS, mean ± SD | 1.438 ± 0.5607 |
| GCS, mean ± SD | 14.95 ± 0.2233 |
| Risk factors | |
| Hypertension, n (%) | 144 (68.57%) |
| Diabetes, n (%) | 70 (33.33%) |
| Disorder of lipid metabolism, n (%) | 33 (15.71%) |
| Atrial fibrillation, n (%) | 20 (9.52%) |
| Coronary artery disease, n (%) | 10 (4.76%) |
| Smoking, n (%) | 41 (19.52%) |
| Drinking, n (%) | 24 (11.43%) |
SD: standard deviation; tPA: tissue plasminogen activator; NIHSS: National Institutes of Health Stroke Scale; mRS: modified Rankin Scale; GCS: Glasgow Coma Scale; LDL: low density lipoprotein.